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The Diarrheal Response of Humans to Some Classic Serotypes of 
Enteropathogenic Escherichia coli is Dependent on a Plasmid Encoding 
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James B. Kaper, Robert E. Black, 
Mary Lou Clements, and Alison D. O'Brien 
From the Center for Vaccine Development, Division of 
Geographic Medicine, University ofMaryland 
School of Medicine, Baltimore; the Department 
of Microbiology, Uniformed Services University 
of the Health Sciences, Bethesda, Maryland; and 
the Institut fur Medizinische Mikrobiologie and 
Immunologie, Universitats-Krankenhaus Eppendorf, 
Arbeiten Krankenhaushygiene, Hamburg, 
Federal Republic of Germany 
Isolates of the most common 0 serogroups of enteropathogenic Es herichia coli (EPEC) 
associated with infant diarrhea (designated class I) adhere to Hep-2 cells; the genes for 
this adhesin, termed EPEC adherence factor (EAF), are located on plasmids 50-70 MDa 
in size. Volunteers ingested 1010 organisms of an 0127:H6 Hep-2-adhesive class I strain 
(E2348/69) or its plasmid-minus, nonadhesive derivative. Diarrhea occurred in nine of 
10 volunteers who ingested the parent strain (mean, 1,178 ml) but in only two of nine 
who took the plasmid-minus variant (mean, 433 ml; P < .006). All volunteers illfrom 
strain E2348/69 mounted serum IgA and IgG responses to a 94-kDa plasmid-associated 
outer membrane protein of E2348/69; this protein was found in other class I EPEC but 
not in enterotoxigenic or meningitic strains. The 50-70-MDa EAF plasmid seems neces- 
sary for full expression of pathogenicity in EPEC that exhibit Hep-2 adhesiveness. EPEC 
isolates of certain other, less common, 0 serogroups (044, 086, and 0114) are rarely 
Hep-2 adhesive. These EPEC, designated class II, possess distinct 50-70 MDa plasmids 
lacking EAF genes. Diarrhea was caused by 108 or 1010 organisms of an 0114:H2 class 
II EPEC strain (mean, 1,156 ml) in six of 11 volunteers. This result confirmed that class 
II EPEC are pathogenic by a mechanism not involving Hep-2 adhesiveness. 
Enteropathogenic Escherichia coli (EPEC) refers to 
certain serotypes of E. coli that were first incrimi- 
nated in epidemiological studies in the 1940s and 
1950s as causes of epidemic and sporadic infant di- 
arrhea [1-5]. By the late 1950s, the standard tech- 
nique for detecting these pathogens involved iden- 
tifying them by agglutination with appropriate 
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antisera [6-8]. Although no biochemical, microbio- 
logical or animal-model assays at that time could 
demonstrate n inherent pathogenicity vis-a-vis other 
E. coli, experimental challenge studies in the early 
1950s in the United States, England, and Japan con- 
firmed that strains of serogroups 055, 0111, and 
0127, isolated from infants with gastroenteritis, 
caused diarrhea when fed to volunteers [9-14]. Also 
at this time, Ewing et al. [6, 8, 15] in the United States 
and Taylor [7] in England noted that among all the 
EPEC, certain 0 serogroups, including 026, 055, 
0111, 0119, 0127, and 0128, were particularly fre- 
quent and epidemiologically well-incriminated in as- 
sociation with diarrhea, whereas isolates of other 
EPEC 0 serogroups, such as 044, 086, and 0114, 
were less common. Serogroup 0142 had not yet been 
recognized as an EPEC at the time of those publi- 
cations. 
Interest inthe pathogenesis of EPEC diarrhea was 
markedly renewed in 1978, when it was shown that 
EPEC strains of serogroups 0127 and 0142 caused 
a notable diarrheal i lness in young adult volunteers 
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[16], although these strains did not elaborate heat- 
labile (LT) or heat-stable (ST) enterotoxins and did 
not manifest shigella-like invasiveness for epithelial 
cells. These investigators concluded that EPEC cause 
diarrhea by other pathogenetic mechanisms. Shortly 
thereafter, Cravioto et al. [17] found that 80% of 
the EPEC strains that they examined adhered to 
Hep-2 cells in tissue culture in the presence of D- 
mannose, a property found to be uncommon i other 
E. coli. Examination of the ultrastructure of EPEC 
infection i  intestinal biopsies of ill infants [18, 19] 
and in animal models [20, 21] has revealed a distinct 
histopathologic lesion in which the EPEC intimately 
adhere to enterocytes, an occurrence r sulting in dis- 
solution of microvilli and cupping of the enterocyte 
outer membrane around the bacteria. So far, this le- 
sion has been identified ininfections due to EPEC 
of serogroups 026, 055, 0111, 0114, 0119, 0125, 
0127, and 0142. 
Baldini et al. [22] noted that 31 of 32 EPEC strains 
possessed a plasmid 50-70 MDa in size. Working 
with E2348/69, an 0127:H6 strain that causes diar- 
rhea in volunteers, these workers found that he genes 
encoding Hep-2 adhesiveness and the ability to ad- 
here to the intestinal mucosa of colostrum-deprived 
piglets are encoded on a 60-MDa plasmid. The term 
EPEC adherence factor (EAF) has been suggested 
to refer to the plasmid-mediated adhesin that con- 
fers Hep-2 adherence. 
Nataro et al. [23, 24] and Baldini et al. [25] have 
isolated a one-kilobase pair (Kb) fragment from the 
60-MDa plasmid of E2348/69 that has proved to be 
a highly sensitive and specific DNA hybridization 
probe for detecting EPEC strains that exhibit Hep- 
2 adhesiveness. In field studies in Peru with this DNA 
gene probe, these workers noted that Hep-2 adhe- 
siveness was more frequently found among EPEC 
serogroups considered to be the most important 
causes of epidemic and sporadic EPEC diarrhea 
worldwide and that this trait correlated with the 
pathogenicity of these strains. In contrast, EPEC of 
the serogroups 044, 086, and 0114, rarely found 
causing outbreaks and of generally lesser significance 
in sporadic diarrhea, were associated with diarrhea 
though they did not carry genes for EAR In light 
of these observations, Nataro suggested the follow- 
ing designations: class I for serogroups 055, 0111, 
0119, 0127, 0128, and 0142; and class II for 
serogroups 044, 086, and 0114. 
Volunteer studies with representative class I and 
II EPEC strains were carried out to determine 
whether the 60-MDa plasmid of E2348/69 
(0127:H6) affects pathogenicity and whether an 
0114:H2 class II EPEC is capable of causing diar- 
rhea, although lacking the genes for Hep-2 adhe- 
siveness. 
Subjects and Methods 
Bacterial strains. E. coli strain E2348/69 
(0127:H6), isolated uring an outbreak of infant di- 
arrhea in Taunton, England [26], was provided by 
Bernard Rowe (Division of Enteric Pathogens, Cen- 
tral Public Health Laboratory, London). Strain 
E2348/69 possesses plasmids of 60 and 5 MDa [22], 
adheres to and forms microcolonies on Hep-2 cells 
[22], attaches to the intestinal mucosa of colostrum- 
deprived piglets [21], and hybridizes with a gene 
probe that detects Hep-2-adhesion genes [23, 24]. 
Strain MAR 20 is a derivative of E2348/69 cured of 
the 60-MDa plasmid, as described previously [22], 
that cannot adhere to Hep-2 cells or piglet intesti- 
nal mucosa and is probe negative. E. coli E128010 
(0114:H2) was isolated from an infant with sporadic 
diarrhea in Bangladesh [27]. This strain possesses 
two plasmids, of 50 and 60 MDa, but does not ad- 
here to Hep-2 cells and is probe negative. As previ- 
ously reported, the above strains do not carry genes 
for ST or LT production, do not hemagglutinate hu- 
man or bovine red blood cells, and are not invasive 
in the guinea pig keratoconjunctivitis test [16, 27, 
28]. Other pertinent microbiological and biologic 
properties of these strains are summarized intable 1. 
Strains E2348/69, MAR 20, and E128010 were x- 
amined for their ability to produce Shiga-like toxin 
by the HeLa-cell cytotoxicity method of O'Brien et 
al. [29]. Extracts of strains that were cytotoxic for 
HeLa cells were reacted with specific Shiga antitoxin 
to determine if the cytotoxicity could be neutralized. 
Nine other E. coli strains were selected for exami- 
nation of their outer membrane proteins. These in- 
cluded the following: enterotoxigenic E. oli strains 
132C (06:H16), H10407 (078:H11), M424C1 
(06:H16), and B7A (0148:H28) [30, 31]; strains 
RS188 (07:K1:H -) and R5408 (075:K1), associated 
with neonatal meningitis and provided by Richard 
Silver (Bureau of Biologics, Bethesda, Md); EPEC 
strain E851/71 (0142:H6) [16]; and EPEC strains 
0659/79 (0119:H6) and 2340/78 (0111a,b:H ), 
provided by I. Kaye Wachsmuth (Centers for Dis- 
ease Control, Atlanta). 
Volunteers and study design. Volunteers were 
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Table 1. Biologic characteristics of three nteropathogenic strains of E. coli fed to healthy adult volunteers. 
DNA hybridization 
Adhesion to Hep-2 cells Plasmids probe for Hep-2- 
Strain Origin Serotype with microcolony formation (MDa) adhesive (EAF) genes 
E2348/69 Infant nursery diarrhea outbreak, 0127:H6 + 60 + 
Taunton, England 
5 
MAR 20 Laboratory-derived, plasmid- 0127:H6 - 5 - 
cured variant of E2348/69 
E128010 Sporadic infant diarrhea, 0114:H2 - 60 - 
Bangladesh 50 
college students and other healthy adults aged 18-35 
years from the Baltimore community; they were ad- 
mitted to the 22-bed Isolation Ward of the Center 
for Vaccine Development for a period of 12 days. 
Methods of recruitment, medical screening, and clin- 
ical supervision have been previously described [16, 
32]. The studies were xplained in detail to the volun- 
teers and signed, witnessed consent was obtained. 
In order to ensure the informed nature of consent, 
volunteers were required to pass a written examina- 
tion containing multiple choice and true-false ques- 
tions on all aspects of the study, including risks, 
benefits, procedures, and microbiology [16, 32]. 
In the first study, 19 volunteers were randomly cho- 
sen to receive 1010 E. coli strain E2348/69 or its 
plasmid-minus derivative, E. coli strain MAR 20. 
Neither the clinical observers nor the volunteers were 
aware of which strain they received. 
In the second study, a total of 11 volunteers e- 
ceived 108 or 1010 E. coli strain E128010. The inoc- 
ula for bacterial challenge were prepared as previ- 
ously described [16] and were fed to fasting 
volunteers with 2.0 g NaHCO3 in 150 ml of water. 
The volunteers were closely observed for a period 
of 96 hr after challenge, during which time all stools 
were collected, examined, graded, and cultured. Rec- 
tal swabs were obtained if a daily stool was not 
passed. Diarrhea was defined as two or more loose 
stools within 48 hr totalling at least 200 ml in vol- 
ume or a single loose stool of 300 ml in volume 
[32]. After 96 hr of observation, all volunteers were 
given oral neomycin (500 mg every 6 hr) or 
colistimethate (300 mg every 8 hr) for five days to 
eradicate the challenge strains. 
Bacteriology. Stools and rectal swabs were cul- 
tured on Levine's eosin methylene blue (EMB) agar 
with and without nalidixic acid, 50 pig/m1 (all chal- 
lenge strains were nalidixic-acid resistant). Quantita- 
tive stool cultures were performed as previously de- 
scribed [16]. 
Probe hybridization. From stool cultures of 
volunteers who ingested E2348/69, lactose-positive 
colonies from the EMB plate containing nalidixic 
acid were agglutinated with OK antiserum prepared 
to E2348/69. After challenge, five agglutinating 
colonies per volunteer per day were saved to be tested 
with the DNA probe that detects the Hep-2-adher- 
ence genes. The colony hybridization technique of 
Moseley et al. [33] was followed with stringent con- 
ditions (50% formamide). In this way, the stability 
of the 60-MDa plasmid of E2348/69 in human in- 
testinal infection was assessed. 
Plasmid extraction. Plasmid extraction was per- 
formed by the rapid alkaline-extraction procedure 
of Birnboim and Doly [34], and plasmid profiles 
were visualized after electrophoresis through 0.7% 
agarose gels. 
Serology. Sera collected before and 10, 21, and 
28 days after challenge were xamined for antibody 
to 0127 or 0114 0 antigens by using the passive HA 
technique as previously described [16, 35]. The 0127 
lipopolysaccharide was a phenol-water p eparation 
(List Biologicals, Campbell, Calif) [36]. The 0114 
antigen was obtained by heat-alkaline treatment [37]. 
Outer membrane preparations. The E. coli 
strains were grown overnight in Pen Assay broth 
(Difco, Detroit) at 37 C, and outer membrane prepa- 
rations (OMPs) were made by the method of Acht- 
man et al. [38]. The protein content of the OMPs 
was measured by the technique of Markwell [39]. 
Samples of OMP (containing 30ug of protein) were 
electrophoresed in 11% polyacrylamide g l by the 
technique of Lugtenberg et al. [40] in the presence 
of SDS and the electrophorogram stained with 
coomassie blue. 
Immunoblotting. Replicate 200-pig samples of 
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E2348/69 OMP were subjected to SDS-PAGE. Af- 
ter electrophoresis, the proteins were transferred from 
polyacrylamide gel to nitrocellulose paper by vacuum 
blotting for 2 hr by the procedure of Peferoen et al. 
[41], and the paper was cut into strips. The unab- 
sorbed sites on the strips were blocked by incuba- 
tion for 1 hr at room temperature in PBS containing 
0.5% polyoxylenesorbitan mo olaurate (Tween-20; 
Fisher Chemical, Pittsburgh). The strips were then 
incubated overnight in 2 ml of pre- (day 0) or post- 
challenge (day 28) human serum (challenged with 
E2348/69 or MAR 20) diluted 1:100 in PBS contain- 
ing 0.5% Tween-20. The strips were washed three 
times (20 min each) in buffer before adding alkaline 
phosphatase-conjugated goat antibody to human 
IgA or antibody to IgG (Jackson Immunoresearch, 
Hamburg, FRG) for 2 hr at room temperature. Fol- 
lowing three 10-min washes in PBS/0.507o Tween-20, 
the strips were xposed to 5-bromo-4-chloroindoxyl 
phosphate (Sigma, St. Louis) substrate in the pres- 
ence of nitroblue t trazolium (Sigma), according to 
the method of Blake et al. [42], for 10 min at 37 C 
to develop a colorimetric reaction. In later experi- 
ments, OMPs of the other strains were submitted to
PAGE, vacuum blotted onto nitrocellulose filters, 
reacted with day-28 convalescent serum from a 
volunteer who developed diarrhea with strain 
E2348/69, and treated with conjugated antibody to 
IgA followed by substrate. 
Results 
Class I EPEC. Shiga toxin. Both strain 
E2348/69 and its plasmid-minus derivative MAR 20 
produced trace amounts of a Shiga-like toxin that 
was neutralized by specific Shiga antitoxin. Trace 
amounts of Shiga-like toxin were defined as <200 
50% HeLa-cell cytotoxic doses per mg of cell-lysate 
protein. 
Clinical. Diarrhea occurred in nine (90%) of 10 
volunteers who received strain E2348/69 but in only 
two (22%) of nine who ingested the plasmid-minus 
derivative, MAR 20 (P < .006; table 2). The two ill 
volunteers who received the plasmid-minus deriva- 
tive had milder diarrhea (mean stool volume, 433 ml) 
than did those who ingested the parent strain (mean 
stool volume, 1,178 ml). Most of the volunteers who 
ingested strain E2348/69 developed anorexia, mal- 
aise, and abdominal gurgling, whereas these symp- 
toms were not seen in the two volunteers who devel- 
oped mild diarrhea fter ingestion of MAR 20. 
Bacteriology. All volunteers became colonized 
by the organism they ingested, and the geometric 
mean level of fecal excretion was similar in both 
groups (7.3 x 10' E2348/g and 2.6 x 108 MAR 
20/g). 
Isolates of E2348/69 from stool cultures of volun- 
teers who ingested that strain were tested for the pres- 
ence of the Hep-2-adhesive g nes by means of a gene 
probe. Of 174 E2348/69 isolates tested, only 57 
(3301o) were positive with the probe. Sixty of the 174 
isolates were randomly selected for plasmid analy- 
sis. All the probe-negative isolates also lacked the 
60-MDa plasmid; in contrast, all probe-positive iso- 
lates possessed the plasmid. The proportion of 
plasmid-minus, Hep-2-negative isolates was similar 
on all postchallenge days. 
The possibility that spontaneous curing of the 
plasmid occurred in the act of preparation of the 
challenge inoculum was examined by a reconstruc- 
tion experiment, in which the inoculum-preparation 
procedure was repeated and the organisms probed 
Table 2. Clinical response of volunteers after ingestion of an 0127:H6 EPEC (class I) strain with and without its 
60-MDa plasmid or of an 0114:H2, class II EPEC. 
Diarrhea Mean diarrheal Positive 
Strain ingested Dose attack rate* stool volume (range) stool cultures* 
E2348/69 (0127:H6, with plasmid) 1010 9/10t 1,178 ml 
(207-3,224) 
10/10 
MAR 20 (0127:H6, without plasmid) 1010 2/9t 9/9 
433 ml 
(269-596) 
E128010 (0114:H2) 108 3/6 
1010 3/5 
1,090 ml 
(328-2,045) 
1,225 ml 
(390-1,785) 
6/6 
5/5 
* No. positive/no. of volunteers challenged. 
t P < .006 by two-tailed Fisher's exact test. 
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Figure 1. SDS-PAGE of outer membrane preparations 
(OMP) of E. coli strain E2348/69 (lane A) and its 
plasmid-minus derivative, MAR 20 (lane B). Molecular 
weight standards are in lane C (Low Molecular Weight 
Standards Kit; Pharmacia, Uppsala, Sweden). The upper 
arrow points to a prominent doublet protein band. The 
lower arrow points to a faint protein band. 
after plating on Luria-agar (L-agar). The possibil- 
ity that spontaneous cure occurred during the 
coproculture procedure was also examined by pass- 
ing a fresh inoculum twice on EMB agar and twice 
on L-agar to mimic the clinical microbiological pro- 
cedure and then performing the DNA hybridization. 
In both these instances, the prevalence of plasmid- 
minus isolates of E2348/69 was <107o f all colonies 
tested. Thus, the high prevalence (67%) of plasmid- 
minus colonies isolated from stool cultures of volun- 
teers implies that plasmid curing occurred in vivo, 
in the human intestine. 
Serology. The rate of seroconversion (>fourfold 
rise) to 0127 antigen was similar in volunteers who 
ingested E2348/69 (eight of 10) and MAR 20 (eight 
of nine). The peak geometric mean titer after chal- 
lenge among those who exhibited seroconversions 
was 49 in the E2348/69 recipients and 41 in those 
who ingested MAR 20. 
Outer membrane profile. Analysis of the OMP 
of E. coli strains E2348/69 and MAR 20 (figure 1) 
reveals a 94-kDa protein and a minor 31-kDa pro- 
tein that are absent in the plasmid-minus derivative, 
MAR 20. 
Immunoblotting. Prechallenge (day 0) and post- 
challenge (day 28) sera from volunteers who ingested 
either E. coli strain E2348/69 or its plasmid-minus 
derivative MAR 20, were tested in an immunoblot- 
ting procedure for the presence of specific IgA and 
IgG antibodies to E2348/69 OMP antigens. 
Results with the conjugated antibody to IgA 
shown in figure 2A clearly demonstrate hat volun- 
teers challenged with the plasmid-containing parent 
strain, E2348/69, mounted a notable immune re- 
sponse to the 94-kDa plasmid-associated protein. 
One of 10 recipients of strain E2348/69 (volunteer 
4) had detectable antibody to this protein in the pre- 
challenge specimen. In the convalescent (day 28) sera, 
however, all 10 recipients of E2348/69 showed anti- 
body to the 94-KDa protein, a result demonstrating 
that all nine seronegative olunteers seroconverted. 
It is of interest that the one volunteer who failed to 
develop diarrhea after ingestion of E2348/69 (table 
2) was the individual in this group who had detect- 
able antibody before challenge. One individual who 
ingested MAR 20 (volunteer 1, figure 2B) had de- 
tectable antibody in both pre- and postchallenge 
specimens; no volunteers inthis group manifested 
seroconversions i  antibody to the 94-kDa protein. 
Identical results were obtained when levels of IgG 
antibody were measured with conjugated antibody 
to IgG (data not shown). An immune response 
to the 31-kDa plasmid-encoded protein was not 
detected. 
In figure 3, the day-28 serum of one E2348/69 
volunteer who seroconverted is shown tested against 
E2348/69 OMP directly and after adsorption with 
MAR 20 or E2348/69 bacteria. The unadsorbed se- 
rum shows a strong antibody reaction to the 94-kDa 
B A 
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1 2 3 L. 5 6 7 8 9 10 
Figure 2. (Top) Immunoblot f sera 
of volunteers who ingested E. coli strain 
E2348/69 tested against strain E2348/ 
69 OMP. The arrow points to the 
94-kDa plasmid-associated protein. 
(Bottom) Immunoblot f sera of vol- 
unteers who ingested E. coli strain 
MAR 20 tested against strain E2348/69 
OMP. The arrow points to the 94-kDa 
plasmid-associated protein. 
1 2 3 L 5 6 7 8 9 
protein and evidence of lesser amounts of antibody 
combining with other proteins (figure 3, lane A). Ad- 
sorption with E2348/69 cells removes virtually all 
antibody (figure 3, lane B). In contrast, adsorption 
with MAR 20 removes antibody to the other OMP 
proteins but leaves antibody to the 94-kDa protein 
(figure 3, lane C). 
In view of the notable immune response demon- 
strated to the presumably plasmid-associated, 94- 
kDa protein, OMPs of 10 other selected strains of 
E. coli were xamined for the presence of the 94-kDa 
protein in immunoblots by using day-28 convales- 
cent sera from a patient who ingested E2348/69 as 
an immunologic probe. Results are shown in table 
3. The four enterotoxigenic E. oli and two menin- 
gitis strains lacked the 94-kDa protein. In contrast, 
the 0119,0111, and 0142 EPEC strains, all of which 
are Hep-2 adhesive and positive with the DNA probe, 
possessed a protein of ru94 kDa that reacted with 
the convalescent antiserum. E. coli E128010, an 0114 
class II EPEC strain (see below) that is negative with 
the EAF gene probe and does not adhere to Hep-2 
cells, was negative for the 94-kDa protein. 
Class II EPEC. The 0114:H2 EPEC strain 
(E128010) that was fed to volunteers caused un- 
equivocal diarrheal i lness in 5007o-6007o. The clini- 
cal and bacteriologic results are summarized inta- 
ble 2. Like strain E2348/69, E128010 was found to 
produce trace levels of Shiga-like toxin. Nine of 11 
recipients of E128010 manifested serological rises in 
titer to the 0114 antigen. 
Discussion 
Plasmids encode critical virulence properties for en- 
terotoxigenic [43-45], enteroinvasive [46], and en- 
terohemorrhagic [47]E. coli that cause diarrheal dis- 
ease [27]. It is now obvious that the 50-70-MDa 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
pre day 
28 
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IgG immune response in serum (figures 1-3). This 
94-kDa protein was absent in four enterotoxigenic 
E. coli strains and in two strains from patients with 
neonatal meningitis. In contrast, hree Hep-2-adhe- 
sive, EAF gene probe-positive EPEC strains of 
serogroups 0111, 0142, and 0119 were found to pos- 
sess the 94-kDa outer membrane protein. These pre- 
liminary data suggest hat this protein may play a 
role in the pathogenesis of diarrhea due to EPEC 
strains that cause localized adhesion on Hep-2 cells 
and are positive with the EAF gene probe. Studies 
are underway to investigate this association i  a larger 
and more varied series of E. coli strains. It is of fur- 
ther interest that he one volunteer among the group 
of 10 who did not develop diarrhea when fed E. coli 
strain E2348/69 was the one individual in the group 
who, before challenge, had antibody to the 94 kDa 
Table 3. Occurrence ofa 94-kDa protein in outer mem- 
brane preparations of E. coli strains from various clini- 
cal sources, detected in immunoblots. 
Figure 3. The day-28 postchallenge serum from a 
volunteer who ingested E. coli strain E2348/69 and sero- 
converted to the 94-kDa protein is shown tested against 
strain E2348/69 OMP. The serum was tested unadsorbed 
(lane A) and after adsorption with E2348/69 (lane B) or 
MAR 20 (lane C) bacteria. 
plasmid that is present in class I EPEC also encodes 
genes that greatly affect he pathogenicity of such 
strains in humans. Both of the 0127:H6 strains that 
were fed to volunteers had smooth lipopolysacca- 
ride 0 antigens and elaborated similar levels of 
Shiga-like toxin. Fecal excretion was the same for 
both strains, as was the frequency and magnitude 
of the serum 0-antibody response. However, the 60- 
MDa plasmid apparently encodes or regulates an 
adhesin that is not expressed in the absence of the 
plasmid. OMPs of E2348/69 and MAR 20 were x- 
amined because the observations of Scotland et al. 
[48] suggest hat nonfimbrial adhesins are involved 
in attachment ofEPEC to Hep-2 cells. Our studies 
revealed a 94-kDa outer membrane protein produced 
by E2348/69 but not by MAR 20, to which volun- 
teers who ingested E2348/69 mounted an IgA and 
94-kDa outer 
membrane 
protein de- 
tected with 
Class of immunologic 
E. coli Serotype Source probe 
Enterotoxigenic 
132C 06:H16 travelers' - 
diarrhea 
H10407 078:H11 travelers' - 
diarrhea 
M424C1 06:H16 travelers' - 
diarrhea 
B7A 0148:H28 travelers' - 
diarrhea 
K1 meningitis 
RS188 07:K1 :H - neonatal - 
meningitis 
RS408 075:K71 neonatal - 
meningitis 
EPEC 
0659/78 0119:H6* infant + 
diarrhea 
2430/78 0111a,b:H -* infant + 
diarrhea 
E851/71 0142:H6* infant t 
diarrhea 
E128010 0114:H2 infant - 
diarrhea 
* Serotypes form microcolonies on Hep-2 cells and are posi- 
tive with the EAF gene probe. 
t The outer membrane protein that reacted with the immuno- 
logic probe was 96 kDa. 
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protein. Although this observation i volves only one 
patient, it should encourage further studies to as- 
sess the role of antibody to the 94-kDa protein in 
mediating protection a d to investigate the protein 
as a potentially important antigen in development 
of future vaccines against class I EPEC. 
Because the Hep-2-adherence plasmid is moder- 
ately large, there are ample segments of cryptic DNA 
that conceivably could encode other, currently un- 
recognized, virulence factors. We are currently 
analyzing the protein products of plasmid deriva- 
tives that are specifically inactivated inthe Hep-2-ad- 
herence genes. A future volunteer study with the 
0127:H6 strain, containing the inactivated Hep-2 
genes will definitively elucidate the role of these 
genes. 
A surprise finding was that although the EAF 
plasmid is extremely stable in vitro, considerable 
spontaneous cure was observed after intestinal pas- 
sage. It should be noted that this plasmid loss oc- 
curred after infection of adults, a group not consid- 
ered naturally at high risk for this pathogen, and was 
observed for only one strain [1]. Plasmid loss in the 
intestine ofyoung infants may be much less frequent. 
These data may provide a clue to a better understand- 
ing of the epidemiology of EPEC. For example, 
when identified by serotyping, the difference in rate 
of isolation of EPEC from infants with diarrhea vs. 
healthy controls i  highly significant in infants less 
than six months of age, whereas the rates of isola- 
tion are similar in infants more than six months of 
age [1, 49]. On the basis of observations in the volun- 
teer studies described herein, one would want in fu- 
ture epidemiological studies to ascertain whether the 
fecal isolates from class I EPEC from cases and con- 
trols of various ages possess EAF. It is conceivable 
that although the isolation of EAF-positive EPEC 
is high in very young infants with diarrhea, older 
children and healthy controls may more often be 
colonized with nonpathogenic, plasmid-minus var- 
iants, like our volunteers who were colonized with 
MAR 20. The observation of in vivo plasmid loss 
in volunteers also provides a note of caution to in- 
vestigators examining EPEC strains from sporadic 
cases of diarrhea or from outbreaks. Multiple iso- 
lates from each individual must be examined before 
concluding that the implicated EPEC strain lacks 
the EAF plasmid. Epidemiological studies are un- 
derway to test these hypotheses. 
Strain E128010, an 0114:H2 class II EPEC that 
contains two large (50- and 60-MDa) plasmids but 
is Hep-2 negative and probe negative, nevertheless 
caused diarrhea of a severity equal to that in volun- 
teers who ingested E2348/69 (table 3). This shows 
that EPEC strains of the serogroups recognized by 
Ewing et al. [6, 8, 15] and Taylor [7] as being less- 
important causes of diarrhea (in comparison with 
class I EPEC), are nevertheless clearly diarrheagenic 
pathogens. Studies are commencing to investigate 
whether the presumably distinct 50-70-MDa plas- 
mids found in class II EPEC, such as E128010, play 
a role in pathogenicity. 
Results of the volunteer studies corroborate he 
epidemiological findings of Nataro et al. [24] who, 
on the basis of examination of a large number of 
isolates from Peru, concluded that EAF is impor- 
tant for the pathogenicity of 0 serogroups designated 
class I (which includes 055, 0111, 0119, 0127, 0128, 
and 0142), and that EPEC strains of class II (which 
contains the less common 044, 086, and 0114 
serogroups) are also pathogenic, even though they 
typically lack EAF. It is hoped that the preliminary 
studies described herein will stimulate other investi- 
gators to undertake studies of the pathogenicity of 
class I and class II EPEC. 
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